reports
NNIT A/S: NNIT shares its financial calendar for 2026
NNIT A/S: NNIT shares its financial calendar for 2026 The financial calendar for 2026: 28 January 2026Deadline for shareholder proposals for the Annual General Meeting5 February 2026Interim Financial Report Q4 2025 and Annual Report 202512 March 2026Annual General Meeting12 May 2026Interim Financial Report Q1 202627 August 2026Interim Financial Report H1 20265 November 2026Interim Financial Report Q3 2026 For more information, please contact: Investor RelationsCarsten RingiusEVP & CFOTel: Media RelationsThomas StensbølPress & Communications ManagerTel: ABOUT NNIT NNIT is a leadi...
- ABGSC IT Research
- Mikkel Kousgaard Rasmussen
- ABGSC IT Research
- Mikkel Kousgaard Rasmussen
NNIT A/S: On-track performance with doubled profitability
NNIT A/S: On-track performance with doubled profitability Q3 2025 key highlights While business was still being negatively impacted by macroeconomic and geopolitical uncertainty, there was an uplift in financial performance in the third quarter. Group operating profit excluding special items more than doubled at DKK 35.6m, corresponding to a margin of 8.2% against 3.9% in the third quarter of 2024. The step-change in margin development compared with last quarter and last year was driven by more efficient operations in terms of improving utilization and the effect from cost reducing initiat...
NNIT A/S: NNIT restates its life science segment in its financial repo...
NNIT A/S: NNIT restates its life science segment in its financial reporting structure Today, NNIT announces an update to its financial reporting structure to ensure that all Life Sciences customers are fully consolidated under Region Europe, US, and Asia. As a result, all Life Science customers previously reported under Region Denmark irrespective of the business activity will now be included in Region Europe’s profit and loss statement. Going forward, Region Denmark will consist solely of the Public segment and the Private segment, which includes SCALES. The restatement of the Life Scienc...
- ABGSC IT Research
- Mikkel Kousgaard Rasmussen
- ABGSC IT Research
- Mikkel Kousgaard Rasmussen
- ABGSC IT Research
- Mikkel Kousgaard Rasmussen
NNIT A/S: NNIT improved profitability amid negative growth due to mark...
NNIT A/S: NNIT improved profitability amid negative growth due to market uncertainty Q2 2025 key highlights In the second quarter, the financial performance continued to be impacted by macroeconomic and geopolitical uncertainty. The market unrest led to a slowdown in the IT Life Science consultancy industry with lower expectations to market growth compared with the start of the year1, especially affecting Region Europe. Furthermore, the timing of Easter had negative revenue implications, especially in Region Europe and Denmark. Towards the end of the quarter, NNIT saw early signs of improv...
- ABGSC IT Research
- Mikkel Kousgaard Rasmussen
- ABGSC IT Research
- Mikkel Kousgaard Rasmussen
- ABGSC IT Research
- Mikkel Kousgaard Rasmussen
NNIT A/S: Business performance impacted by market undercetainty expect...
NNIT A/S: Business performance impacted by market undercetainty expected to continue. Mitigating actions taken to protect profitability Q1 2025 key highlights Financial performance for the first quarter was expected to be moderate, but macroeconomic and geopolitical uncertainty increased, which impacted NNIT. The uncertainty has influenced customer behavior, especially in the three regions focusing on IT Life Science solutions, where several projects have been postponed, most predominantly in Region Europe. Group revenue amounted to DKK 464.1m, entailing flat revenue growth compared with l...
NNIT A/S: NNIT adjusts 2025 outlook and publishes Q1 figures
NNIT A/S: NNIT adjusts 2025 outlook and publishes Q1 figures The first quarter financial performance was expected to be moderate, but the increased macroeconomic and geopolitical uncertainty has impacted NNIT to a larger extent than expected. Based on the realized results and the continued uncertainty, NNIT adjusts the 2025 financial outlook. Given the current uncertainty, organic revenue growth is expected to be 0% to 5% (previously 7% to 10%), which is due to postponement of projects and the sales pipeline materializing at a slower pace than planned as customers are hesitating to engage...
- ABGSC IT Research
- Mikkel Kousgaard Rasmussen
NNIT A/S: Resolutions from the annual general meeting of NNIT A/S
NNIT A/S: Resolutions from the annual general meeting of NNIT A/S Today, NNIT A/S held its annual general meeting, at which the following were noted/approved: Financial year 2024 and 2025 The Chairman of the Board gave the Board of Directors’ report on the Company’s activities in the past financial year, especially highlighting: NNIT is now a highly specialized IT consultancy firm with a focus on Life Sciences internationally and the public sector in Denmark.Revenue growth has been higher than the market despite lowered financial expectations during the year.Several new customers have ...
- ABGSC IT Research
- Mikkel Kousgaard Rasmussen
NNIT A/S: Notice convening the annual general meeting for NNIT A/S
NNIT A/S: Notice convening the annual general meeting for NNIT A/S The Board of Directors gives notice of the annual general meeting for NNIT A/S, company registration (CVR) no. 21 09 31 06 (the “Company”), to be held Thursday, March 13, 2025, 2:00 pm (CET) at Novo Holdings A/S, Tuborg Havnevej 19, DK-2900 Hellerup. The general meeting will for shareholders be webcasted live on the Company’s investor portal. It is not possible to vote or ask questions via webcast. The notice for the annual general meeting, including Appendix A: Candidates for (re-)election to the Board of Directors, is at...
- ABGSC IT Research
- Mikkel Kousgaard Rasmussen
NNIT A/S: NNIT RELEASES ITS ANNUAL REPORT FOR 2024
NNIT A/S: NNIT RELEASES ITS ANNUAL REPORT FOR 2024 Annual Report 2024 2024 was the first full year as the new NNIT – an industry focused specialized IT consultancy focusing on Life Sciences internationally and the public and private sectors in Denmark. The Group continued to grow revenue organically and deliver a profit margin in line with the updated outlook for the year. 2024 key highlights Revenue grew by 7.1% (organic growth of 6.0%) to DKK 1,851 million. Despite facing challenges in various regions, especially in the third quarter, we ultimately achieved growth that surpassed the...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.